Fungal keratitis in London: Microbiological and clinical evaluation

Cornea

Volumn 26, Issue 9, 2007, Pages 1082-1086

  Galarreta, David J ^a   Tuft, Stephen J ^a,b   Ramsay, Andrew ^a   Dart, John K G ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Filamentary fungus; Fungal keratitis; Keratomycosis; Sensitivity testing; Yeast

Indexed keywords

AMPHOTERICIN; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; STEROID; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; CANDIDIASIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNGUS IDENTIFICATION; HUMAN; KERATOMYCOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; YEAST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; FEMALE; FUNGI; HUMANS; LONDON; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34748910024     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318142bff3     Document Type: Article

References (43)

1. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211-1215.
2. Mino de Kaspar H, Zoulek G, Paredes ME, et al. Mycotic keratitis in Paraguay. Mycoses. 1991;34:251-254.
3. Xie L, Zhong W, Shi W, et al. Spectrum of fungal keratitis in North China. Ophthalmology. 2006;113:1943-1948.
4. Ritterband DC, Seedor JA, Shah MK, et al. Fungal keratitis at the New York eye and ear infirmary. Cornea. 2006;25:264-267.
5. Bhartiya P, Daniell M, Constantinou M, et al. Fungal keratitis in Melbourne. Clin Experiment Ophthalmol. 2007;35:124-130.
6. Thygeson P, Okumoto M. Keratomycosis: a preventable disease. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:OP433-OP439.
7. Chin GN, Hyndiuk RA, Kwasny GP, et al. Keratomycosis in Wisconsin. Am J Ophthalmol. 1975;79:121-125.
8. Foster CS. Miconazole therapy for keratomycosis. Am J Ophthalmol. 1981;91:622-629.
9. Doughman DJ, Leavenworth NM, Campbell RC, et al. Fungal keratitis at the University of Minnesota: 1971-1981. Trans Am Ophthalmol Soc. 1982;80:235-247.
10. O'Day DM. Selection of appropriate antifungal therapy. Cornea. 1987;6:238-245.
11. Kelly LD, Pavan-Langston D, Baker AS. Keratomycosis in a New England referral center: spectrum of pathogenic organisms and predisposing factors. In: Bialasiewicz AA, Schaal KP, eds. Infectious Diseases of the Eye. Boston, MA: Butterworth-Heinemann; 1994:184-190.
12. Griffiths MFP, Clayton YM, Dart JKG. Antifungal sensitivity testing of keratitis isolates at Moorfields Eye Hospital 1975-1990: therapeutic implications. In: Bialasiewicz AA, Schaal KP, eds. Infectious Diseases of the Eye. Boston, MA: Butterworth-Heinemann; 1994:190-194.
13. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19:307-312.
14. Rondeau N, Bourcier T, Chaumeil C, et al. [Fungal keratitis at the Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts: retrospective study of 19 cases]. J Fr Ophtalmol. 2002;25:890-896.
15. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90:38-47.
16. Miedziak AI, Miller MR, Rapuano CJ, et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999;106:1166-1170.
17. Thomas PA. Fungal infections of the cornea. Eye. 2003;17:852-862.
18. O'Day DM, Head WS. Advances in the management of keratomycosis and Acanthamoeba keratitis. Cornea. 2000;19:681-687.
19. Johns KJ, O'Day DM. Pharmacologic management of keratomycoses. Surv Ophthalmol. 1988;33:178-188.
20. Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol. 2001;85:1070-1074.
21. Xie L, Shi W, Liu Z, et al. Lamellar keratoplasty for the treatment of fungal keratitis. Cornea. 2002;21:33-37.
22. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A. Clinical and Laboratory Standards Institute, Wayne, PA, 2002.
23. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 2nd ed. CLSI document M27-A2. Clinical and Laboratory Standards Institute, Wayne, PA, 2002.
24. Kuriakose T, Kothari M, Paul P, et al. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea. 2002;21:653-656.
25. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214-221.
26. Houang E, Lam D, Fan D, et al. Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection. Trans R Soc Trop Med Hyg. 2001;95:361-367.
27. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997;81:965-971.
28. Gopinathan U, Garg P, Fernandes M, et al. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002;21:555-559.
29. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology. 1994;101:1005-1013.
30. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol. 2003;51:315-321.
31. Ross HW, Laibson PR. Keratomycosis. Am J Ophthalmol. 1972;74:438-441.
32. Foster CS. Fungal keratitis. Infect Dis Clin North Am. 1992;6:851-857.
33. Chowdhary A, Singh K. Spectrum of fungal keratitis in North India. Cornea. 2005;24:8-15.
34. Berson EL, Kobayashi GS, Becker B, et al. Topical corticosteroids and fungal keratitis. Invest Ophthalmol. 1967;6:512-517.
35. Harris DJ Jr, Stulting RD, Waring GO III, et al. Late bacterial and fungal keratitis after corneal transplantation. Spectrum of pathogens, graft survival, and visual prognosis. Ophthalmology. 1988;95:1450-1457.
36. Fong LP, Ormerod LD, Kenyon KR, et al. Microbial keratitis complicating penetrating keratoplasty. Ophthalmology. 1988;95:1269-1275.
37. Alfonso EC, Cantu-Dibildox J, Munir WM, et al. Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol. 2006;124:941-947.
38. Khor WB, Aung T, Saw SM, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295:2867-2873.
39. Wilhelmus KR, Robinson NM, Font RA, et al. Fungal keratitis in contact lens wearers. Am J Ophthalmol. 1988;106:708-714.
40. Prajna NV, John RK, Nirmalan PK, et al. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol. 2003;87:1235-1237.
41. Espinel-Ingroff A. Utility of mould susceptibility testing. Curr Opin Infect Dis. 2003;16:527-532.
42. Savani DV, Perfect JR, Cobo LM, et al. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother. 1987;31:6-10.
43. O'Day DM, Foulds G, Williams TE, et al. Ocular uptake of fluconazole following oral administration. Arch Ophthalmol. 1990;108:1006-1008.